Search research articles
Contact Us
Filters
Showing results (401-410 of 438) with videos related to
Page
of 44
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 6, 2019
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
Lisa Vermunt, Sietske A M Sikkes, Ardo van den Hout, et al.
International Psychogeriatrics
|
November 21, 2013
Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)
Kathryn A Ellis, Cassandra Szoeke, Ashley I Bush, et al.
Journal of Alzheimer'S Disease : JAD
|
January 30, 2018
Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β
W M A D Binosha Fernando, Stephanie R Rainey-Smith, Samantha L Gardener, et al.
Nature Communications
|
September 12, 2024
Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer's disease progression
Xin Huang, Chris Fowler, Yihan Li, et al.
Neurology
|
November 13, 2020
Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older Individuals
Laura M van der Kall, Thanh Truong, Samantha C Burnham, et al.
Brain : a Journal of Neurology
|
August 14, 2016
BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease
Yen Ying Lim, Jason Hassenstab, Carlos Cruchaga, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 9, 2022
Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's disease
Xin Huang, Yihan Li, Christopher Fowler, et al.
Nature Communications
|
September 21, 2022
Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration
Ying Jiang, John J Alam, Stephen N Gomperts, et al.
Schizophrenia Research
|
March 3, 2015
A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy
L Fredrik Jarskog, Martin T Lowy, Richard A Grove, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 1, 2026
Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scans
Azadeh Feizpour, Vincent Doré, Pierrick Bourgeat, et al.
Page
of 44
Search research articles
Search
Showing results (401-410 of 438) with videos related to
Sort By:
Page
of 44
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 6, 2019
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype
Lisa Vermunt, Sietske A M Sikkes, Ardo van den Hout, et al.
International Psychogeriatrics
|
November 21, 2013
Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL)
Kathryn A Ellis, Cassandra Szoeke, Ashley I Bush, et al.
Journal of Alzheimer'S Disease : JAD
|
January 30, 2018
Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-β
W M A D Binosha Fernando, Stephanie R Rainey-Smith, Samantha L Gardener, et al.
Nature Communications
|
September 12, 2024
Clearance and transport of amyloid β by peripheral monocytes correlate with Alzheimer's disease progression
Xin Huang, Chris Fowler, Yihan Li, et al.
Neurology
|
November 13, 2020
Association of β-Amyloid Level, Clinical Progression, and Longitudinal Cognitive Change in Normal Older Individuals
Laura M van der Kall, Thanh Truong, Samantha C Burnham, et al.
Brain : a Journal of Neurology
|
August 14, 2016
BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's disease
Yen Ying Lim, Jason Hassenstab, Carlos Cruchaga, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
November 9, 2022
Leukocyte surface biomarkers implicate deficits of innate immunity in sporadic Alzheimer's disease
Xin Huang, Yihan Li, Christopher Fowler, et al.
Nature Communications
|
September 21, 2022
Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration
Ying Jiang, John J Alam, Stephen N Gomperts, et al.
Schizophrenia Research
|
March 3, 2015
A Phase II study of a histamine H₃ receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy
L Fredrik Jarskog, Martin T Lowy, Richard A Grove, et al.
The Journal of Prevention of Alzheimer'S Disease
|
January 1, 2026
Plasma Aβ42/40 predicts progression from Aβ-amyloid negative to positive PET scans
Azadeh Feizpour, Vincent Doré, Pierrick Bourgeat, et al.
Page
of 44